ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImaBiotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10626
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImaBiotech SAS (ImaBiotech) is a contract research organization that offers mass spectrometry imaging services. The organization’s software products include quantinetix and multimaging. It offers services such as biomarker discovery, consulting and training, screening studies, target engagement studies, pharmaco-kinetics and dynamics studies, MALDI imaging services and toxicology studies. ImaBiotech provides its MALDI imaging services to therapeutic areas such as central nervous system, dermatology and cosmetics, cardiovascular and metabolic diseases, gastroenterology and others. The organization’s consultancy and training services include cost and profitability, feasibility or protocol studies, MALDI imaging mass spectrometry platform installation, project design, data storage, instrumentation and IT and others. It has its operations in France and the US. ImaBiotech is headquartered in Loos, France.

ImaBiotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImaBiotech Raises US$1.37 Million In Venture Financing 11
Partnerships 12
ImaBiotech Enters into Agreement with Dermira 12
Galderma Enters into Agreement with ImaBiotech 13
ImaBiotech Enters Into Agreement With Genfit 14
ImaBiotech SAS – Key Competitors 15
ImaBiotech SAS – Key Employees 16
ImaBiotech SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ImaBiotech SAS, Pharmaceuticals & Healthcare, Key Facts 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaBiotech Raises US$1.37 Million In Venture Financing 11
ImaBiotech Enters into Agreement with Dermira 12
Galderma Enters into Agreement with ImaBiotech 13
ImaBiotech Enters Into Agreement With Genfit 14
ImaBiotech SAS, Key Competitors 15
ImaBiotech SAS, Key Employees 16
ImaBiotech SAS, Subsidiaries 17

List of Figures
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vertex Pharmaceuticals Inc (VRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Orkambi (ivacaftor/lumacaftor) and Kalyd …
  • Jordan French Insurance Co. (P.L.C.):企業の戦略・SWOT・財務情報
    Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report Summary Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Advanced Data Systems Corp-医療機器分野:企業M&A・提携分析
    Summary Advanced Data Systems Corp (ADS) is a healthcare technology company that develops medical billing and office automation software tools. The company offers electronic health records, practice management solution, radiology information systems solutions, revenue cycle management services and b …
  • North Eastern Electric Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary North Eastern Electric Power Corporation Limited (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and sola …
  • Credit Guarantee Insurance Corporation of Africa Ltd:企業の戦略・SWOT・財務分析
    Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report Summary Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Diagnostic Medical Systems SA (DGM):医療機器:M&Aディール及び事業提携情報
    Summary Diagnostic Medical Systems SA (DMS) is a medical device company that designs, manufactures and distributes imaging systems. The company’s products comprise radiography and fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-a …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Eddingpharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eddingpharm Inc (Eddingpharm) is a pharmaceutical company that manufactures and distributes medicines. The company develops products in therapeutic areas such as clinical nutrition, antibiotics, respiratory system, nephrology and cardiovascular. It offers antibiotics including vancocin, cecl …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Endo International plc:企業の戦略・SWOT・財務情報
    Endo International plc - Strategy, SWOT and Corporate Finance Report Summary Endo International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • EFG International AG:企業の戦略・SWOT・財務情報
    EFG International AG - Strategy, SWOT and Corporate Finance Report Summary EFG International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析
    Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nippon Flour Mills Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Presence Health:企業の戦略的SWOT分析
    Presence Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆